COVID-19 Impact on Global Pulmonary Edema Treatment Market Size, Status and Forecast 2020-2026

July 2020 | 93 pages | ID: C8554CC094DEEN
QYResearch

Abstracts

This report focuses on the global Pulmonary Edema Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pulmonary Edema Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Pfizer Inc (US)
• ARGON MEDICAL (US)
• Edwards Lifesciences Corporation (US)
• BD (US)
• Alcaliber S.A. (Spain)
• Lupin Pharmaceuticals (India)
• Vitaltec Corporation (China)
• Medtronic (US)
• Koninklijke Philips N.V. (The Netherlands)
• Siemens Healthcare (Germany)
• Hitachi Medical Corporation (US)
• Canon Medical Systems Corporation (Japan)

Market segment by Type, the product can be split into

• Diagnosis
• Treatment

Market segment by Application, split into

• Hospitals and Clinics
• Academic Institutes
• Retail Pharmacies
• Household
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Pulmonary Edema Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Pulmonary Edema Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Pulmonary Edema Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pulmonary Edema Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Pulmonary Edema Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Diagnosis
  1.4.3 Treatment
1.5 Market by Application
  1.5.1 Global Pulmonary Edema Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals and Clinics
  1.5.3 Academic Institutes
  1.5.4 Retail Pharmacies
  1.5.5 Household
  1.5.6 Other
1.6 Coronavirus Disease 2019 (Covid-19): Pulmonary Edema Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Pulmonary Edema Treatment Industry
    1.6.1.1 Pulmonary Edema Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Pulmonary Edema Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Pulmonary Edema Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Pulmonary Edema Treatment Market Perspective (2015-2026)
2.2 Pulmonary Edema Treatment Growth Trends by Regions
  2.2.1 Pulmonary Edema Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Pulmonary Edema Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Pulmonary Edema Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Pulmonary Edema Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Pulmonary Edema Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Pulmonary Edema Treatment Players by Market Size
  3.1.1 Global Top Pulmonary Edema Treatment Players by Revenue (2015-2020)
  3.1.2 Global Pulmonary Edema Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Pulmonary Edema Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pulmonary Edema Treatment Market Concentration Ratio
  3.2.1 Global Pulmonary Edema Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Pulmonary Edema Treatment Revenue in 2019
3.3 Pulmonary Edema Treatment Key Players Head office and Area Served
3.4 Key Players Pulmonary Edema Treatment Product Solution and Service
3.5 Date of Enter into Pulmonary Edema Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Pulmonary Edema Treatment Historic Market Size by Type (2015-2020)
4.2 Global Pulmonary Edema Treatment Forecasted Market Size by Type (2021-2026)

5 PULMONARY EDEMA TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Pulmonary Edema Treatment Market Size by Application (2015-2020)
5.2 Global Pulmonary Edema Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Pulmonary Edema Treatment Market Size (2015-2020)
6.2 Pulmonary Edema Treatment Key Players in North America (2019-2020)
6.3 North America Pulmonary Edema Treatment Market Size by Type (2015-2020)
6.4 North America Pulmonary Edema Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Pulmonary Edema Treatment Market Size (2015-2020)
7.2 Pulmonary Edema Treatment Key Players in Europe (2019-2020)
7.3 Europe Pulmonary Edema Treatment Market Size by Type (2015-2020)
7.4 Europe Pulmonary Edema Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Pulmonary Edema Treatment Market Size (2015-2020)
8.2 Pulmonary Edema Treatment Key Players in China (2019-2020)
8.3 China Pulmonary Edema Treatment Market Size by Type (2015-2020)
8.4 China Pulmonary Edema Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Pulmonary Edema Treatment Market Size (2015-2020)
9.2 Pulmonary Edema Treatment Key Players in Japan (2019-2020)
9.3 Japan Pulmonary Edema Treatment Market Size by Type (2015-2020)
9.4 Japan Pulmonary Edema Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Pulmonary Edema Treatment Market Size (2015-2020)
10.2 Pulmonary Edema Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Pulmonary Edema Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Pulmonary Edema Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Pulmonary Edema Treatment Market Size (2015-2020)
11.2 Pulmonary Edema Treatment Key Players in India (2019-2020)
11.3 India Pulmonary Edema Treatment Market Size by Type (2015-2020)
11.4 India Pulmonary Edema Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Pulmonary Edema Treatment Market Size (2015-2020)
12.2 Pulmonary Edema Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Pulmonary Edema Treatment Market Size by Type (2015-2020)
12.4 Central & South America Pulmonary Edema Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Pfizer Inc (US)
  13.1.1 Pfizer Inc (US) Company Details
  13.1.2 Pfizer Inc (US) Business Overview and Its Total Revenue
  13.1.3 Pfizer Inc (US) Pulmonary Edema Treatment Introduction
  13.1.4 Pfizer Inc (US) Revenue in Pulmonary Edema Treatment Business (2015-2020))
  13.1.5 Pfizer Inc (US) Recent Development
13.2 ARGON MEDICAL (US)
  13.2.1 ARGON MEDICAL (US) Company Details
  13.2.2 ARGON MEDICAL (US) Business Overview and Its Total Revenue
  13.2.3 ARGON MEDICAL (US) Pulmonary Edema Treatment Introduction
  13.2.4 ARGON MEDICAL (US) Revenue in Pulmonary Edema Treatment Business (2015-2020)
  13.2.5 ARGON MEDICAL (US) Recent Development
13.3 Edwards Lifesciences Corporation (US)
  13.3.1 Edwards Lifesciences Corporation (US) Company Details
  13.3.2 Edwards Lifesciences Corporation (US) Business Overview and Its Total Revenue
  13.3.3 Edwards Lifesciences Corporation (US) Pulmonary Edema Treatment Introduction
  13.3.4 Edwards Lifesciences Corporation (US) Revenue in Pulmonary Edema Treatment Business (2015-2020)
  13.3.5 Edwards Lifesciences Corporation (US) Recent Development
13.4 BD (US)
  13.4.1 BD (US) Company Details
  13.4.2 BD (US) Business Overview and Its Total Revenue
  13.4.3 BD (US) Pulmonary Edema Treatment Introduction
  13.4.4 BD (US) Revenue in Pulmonary Edema Treatment Business (2015-2020)
  13.4.5 BD (US) Recent Development
13.5 Alcaliber S.A. (Spain)
  13.5.1 Alcaliber S.A. (Spain) Company Details
  13.5.2 Alcaliber S.A. (Spain) Business Overview and Its Total Revenue
  13.5.3 Alcaliber S.A. (Spain) Pulmonary Edema Treatment Introduction
  13.5.4 Alcaliber S.A. (Spain) Revenue in Pulmonary Edema Treatment Business (2015-2020)
  13.5.5 Alcaliber S.A. (Spain) Recent Development
13.6 Lupin Pharmaceuticals (India)
  13.6.1 Lupin Pharmaceuticals (India) Company Details
  13.6.2 Lupin Pharmaceuticals (India) Business Overview and Its Total Revenue
  13.6.3 Lupin Pharmaceuticals (India) Pulmonary Edema Treatment Introduction
  13.6.4 Lupin Pharmaceuticals (India) Revenue in Pulmonary Edema Treatment Business (2015-2020)
  13.6.5 Lupin Pharmaceuticals (India) Recent Development
13.7 Vitaltec Corporation (China)
  13.7.1 Vitaltec Corporation (China) Company Details
  13.7.2 Vitaltec Corporation (China) Business Overview and Its Total Revenue
  13.7.3 Vitaltec Corporation (China) Pulmonary Edema Treatment Introduction
  13.7.4 Vitaltec Corporation (China) Revenue in Pulmonary Edema Treatment Business (2015-2020)
  13.7.5 Vitaltec Corporation (China) Recent Development
13.8 Medtronic (US)
  13.8.1 Medtronic (US) Company Details
  13.8.2 Medtronic (US) Business Overview and Its Total Revenue
  13.8.3 Medtronic (US) Pulmonary Edema Treatment Introduction
  13.8.4 Medtronic (US) Revenue in Pulmonary Edema Treatment Business (2015-2020)
  13.8.5 Medtronic (US) Recent Development
13.9 Koninklijke Philips N.V. (The Netherlands)
  13.9.1 Koninklijke Philips N.V. (The Netherlands) Company Details
  13.9.2 Koninklijke Philips N.V. (The Netherlands) Business Overview and Its Total Revenue
  13.9.3 Koninklijke Philips N.V. (The Netherlands) Pulmonary Edema Treatment Introduction
  13.9.4 Koninklijke Philips N.V. (The Netherlands) Revenue in Pulmonary Edema Treatment Business (2015-2020)
  13.9.5 Koninklijke Philips N.V. (The Netherlands) Recent Development
13.10 Siemens Healthcare (Germany)
  13.10.1 Siemens Healthcare (Germany) Company Details
  13.10.2 Siemens Healthcare (Germany) Business Overview and Its Total Revenue
  13.10.3 Siemens Healthcare (Germany) Pulmonary Edema Treatment Introduction
  13.10.4 Siemens Healthcare (Germany) Revenue in Pulmonary Edema Treatment Business (2015-2020)
  13.10.5 Siemens Healthcare (Germany) Recent Development
13.11 Hitachi Medical Corporation (US)
  10.11.1 Hitachi Medical Corporation (US) Company Details
  10.11.2 Hitachi Medical Corporation (US) Business Overview and Its Total Revenue
  10.11.3 Hitachi Medical Corporation (US) Pulmonary Edema Treatment Introduction
  10.11.4 Hitachi Medical Corporation (US) Revenue in Pulmonary Edema Treatment Business (2015-2020)
  10.11.5 Hitachi Medical Corporation (US) Recent Development
13.12 Canon Medical Systems Corporation (Japan)
  10.12.1 Canon Medical Systems Corporation (Japan) Company Details
  10.12.2 Canon Medical Systems Corporation (Japan) Business Overview and Its Total Revenue
  10.12.3 Canon Medical Systems Corporation (Japan) Pulmonary Edema Treatment Introduction
  10.12.4 Canon Medical Systems Corporation (Japan) Revenue in Pulmonary Edema Treatment Business (2015-2020)
  10.12.5 Canon Medical Systems Corporation (Japan) Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Pulmonary Edema Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Pulmonary Edema Treatment Revenue
Table 3. Ranking of Global Top Pulmonary Edema Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Pulmonary Edema Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Diagnosis
Table 6. Key Players of Treatment
Table 7. COVID-19 Impact Global Market: (Four Pulmonary Edema Treatment Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Pulmonary Edema Treatment Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Pulmonary Edema Treatment Players to Combat Covid-19 Impact
Table 12. Global Pulmonary Edema Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Pulmonary Edema Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Pulmonary Edema Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Pulmonary Edema Treatment Market Share by Regions (2015-2020)
Table 16. Global Pulmonary Edema Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Pulmonary Edema Treatment Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Pulmonary Edema Treatment Market Growth Strategy
Table 22. Main Points Interviewed from Key Pulmonary Edema Treatment Players
Table 23. Global Pulmonary Edema Treatment Revenue by Players (2015-2020) (Million US$)
Table 24. Global Pulmonary Edema Treatment Market Share by Players (2015-2020)
Table 25. Global Top Pulmonary Edema Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pulmonary Edema Treatment as of 2019)
Table 26. Global Pulmonary Edema Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Pulmonary Edema Treatment Product Solution and Service
Table 29. Date of Enter into Pulmonary Edema Treatment Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Pulmonary Edema Treatment Market Size by Type (2015-2020) (Million US$)
Table 32. Global Pulmonary Edema Treatment Market Size Share by Type (2015-2020)
Table 33. Global Pulmonary Edema Treatment Revenue Market Share by Type (2021-2026)
Table 34. Global Pulmonary Edema Treatment Market Size Share by Application (2015-2020)
Table 35. Global Pulmonary Edema Treatment Market Size by Application (2015-2020) (Million US$)
Table 36. Global Pulmonary Edema Treatment Market Size Share by Application (2021-2026)
Table 37. North America Key Players Pulmonary Edema Treatment Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Pulmonary Edema Treatment Market Share (2019-2020)
Table 39. North America Pulmonary Edema Treatment Market Size by Type (2015-2020) (Million US$)
Table 40. North America Pulmonary Edema Treatment Market Share by Type (2015-2020)
Table 41. North America Pulmonary Edema Treatment Market Size by Application (2015-2020) (Million US$)
Table 42. North America Pulmonary Edema Treatment Market Share by Application (2015-2020)
Table 43. Europe Key Players Pulmonary Edema Treatment Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Pulmonary Edema Treatment Market Share (2019-2020)
Table 45. Europe Pulmonary Edema Treatment Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Pulmonary Edema Treatment Market Share by Type (2015-2020)
Table 47. Europe Pulmonary Edema Treatment Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Pulmonary Edema Treatment Market Share by Application (2015-2020)
Table 49. China Key Players Pulmonary Edema Treatment Revenue (2019-2020) (Million US$)
Table 50. China Key Players Pulmonary Edema Treatment Market Share (2019-2020)
Table 51. China Pulmonary Edema Treatment Market Size by Type (2015-2020) (Million US$)
Table 52. China Pulmonary Edema Treatment Market Share by Type (2015-2020)
Table 53. China Pulmonary Edema Treatment Market Size by Application (2015-2020) (Million US$)
Table 54. China Pulmonary Edema Treatment Market Share by Application (2015-2020)
Table 55. Japan Key Players Pulmonary Edema Treatment Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Pulmonary Edema Treatment Market Share (2019-2020)
Table 57. Japan Pulmonary Edema Treatment Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Pulmonary Edema Treatment Market Share by Type (2015-2020)
Table 59. Japan Pulmonary Edema Treatment Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Pulmonary Edema Treatment Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Pulmonary Edema Treatment Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Pulmonary Edema Treatment Market Share (2019-2020)
Table 63. Southeast Asia Pulmonary Edema Treatment Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Pulmonary Edema Treatment Market Share by Type (2015-2020)
Table 65. Southeast Asia Pulmonary Edema Treatment Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Pulmonary Edema Treatment Market Share by Application (2015-2020)
Table 67. India Key Players Pulmonary Edema Treatment Revenue (2019-2020) (Million US$)
Table 68. India Key Players Pulmonary Edema Treatment Market Share (2019-2020)
Table 69. India Pulmonary Edema Treatment Market Size by Type (2015-2020) (Million US$)
Table 70. India Pulmonary Edema Treatment Market Share by Type (2015-2020)
Table 71. India Pulmonary Edema Treatment Market Size by Application (2015-2020) (Million US$)
Table 72. India Pulmonary Edema Treatment Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Pulmonary Edema Treatment Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Pulmonary Edema Treatment Market Share (2019-2020)
Table 75. Central & South America Pulmonary Edema Treatment Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Pulmonary Edema Treatment Market Share by Type (2015-2020)
Table 77. Central & South America Pulmonary Edema Treatment Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Pulmonary Edema Treatment Market Share by Application (2015-2020)
Table 79. Pfizer Inc (US) Company Details
Table 80. Pfizer Inc (US) Business Overview
Table 81. Pfizer Inc (US) Product
Table 82. Pfizer Inc (US) Revenue in Pulmonary Edema Treatment Business (2015-2020) (Million US$)
Table 83. Pfizer Inc (US) Recent Development
Table 84. ARGON MEDICAL (US) Company Details
Table 85. ARGON MEDICAL (US) Business Overview
Table 86. ARGON MEDICAL (US) Product
Table 87. ARGON MEDICAL (US) Revenue in Pulmonary Edema Treatment Business (2015-2020) (Million US$)
Table 88. ARGON MEDICAL (US) Recent Development
Table 89. Edwards Lifesciences Corporation (US) Company Details
Table 90. Edwards Lifesciences Corporation (US) Business Overview
Table 91. Edwards Lifesciences Corporation (US) Product
Table 92. Edwards Lifesciences Corporation (US) Revenue in Pulmonary Edema Treatment Business (2015-2020) (Million US$)
Table 93. Edwards Lifesciences Corporation (US) Recent Development
Table 94. BD (US) Company Details
Table 95. BD (US) Business Overview
Table 96. BD (US) Product
Table 97. BD (US) Revenue in Pulmonary Edema Treatment Business (2015-2020) (Million US$)
Table 98. BD (US) Recent Development
Table 99. Alcaliber S.A. (Spain) Company Details
Table 100. Alcaliber S.A. (Spain) Business Overview
Table 101. Alcaliber S.A. (Spain) Product
Table 102. Alcaliber S.A. (Spain) Revenue in Pulmonary Edema Treatment Business (2015-2020) (Million US$)
Table 103. Alcaliber S.A. (Spain) Recent Development
Table 104. Lupin Pharmaceuticals (India) Company Details
Table 105. Lupin Pharmaceuticals (India) Business Overview
Table 106. Lupin Pharmaceuticals (India) Product
Table 107. Lupin Pharmaceuticals (India) Revenue in Pulmonary Edema Treatment Business (2015-2020) (Million US$)
Table 108. Lupin Pharmaceuticals (India) Recent Development
Table 109. Vitaltec Corporation (China) Company Details
Table 110. Vitaltec Corporation (China) Business Overview
Table 111. Vitaltec Corporation (China) Product
Table 112. Vitaltec Corporation (China) Revenue in Pulmonary Edema Treatment Business (2015-2020) (Million US$)
Table 113. Vitaltec Corporation (China) Recent Development
Table 114. Medtronic (US) Business Overview
Table 115. Medtronic (US) Product
Table 116. Medtronic (US) Company Details
Table 117. Medtronic (US) Revenue in Pulmonary Edema Treatment Business (2015-2020) (Million US$)
Table 118. Medtronic (US) Recent Development
Table 119. Koninklijke Philips N.V. (The Netherlands) Company Details
Table 120. Koninklijke Philips N.V. (The Netherlands) Business Overview
Table 121. Koninklijke Philips N.V. (The Netherlands) Product
Table 122. Koninklijke Philips N.V. (The Netherlands) Revenue in Pulmonary Edema Treatment Business (2015-2020) (Million US$)
Table 123. Koninklijke Philips N.V. (The Netherlands) Recent Development
Table 124. Siemens Healthcare (Germany) Company Details
Table 125. Siemens Healthcare (Germany) Business Overview
Table 126. Siemens Healthcare (Germany) Product
Table 127. Siemens Healthcare (Germany) Revenue in Pulmonary Edema Treatment Business (2015-2020) (Million US$)
Table 128. Siemens Healthcare (Germany) Recent Development
Table 129. Hitachi Medical Corporation (US) Company Details
Table 130. Hitachi Medical Corporation (US) Business Overview
Table 131. Hitachi Medical Corporation (US) Product
Table 132. Hitachi Medical Corporation (US) Revenue in Pulmonary Edema Treatment Business (2015-2020) (Million US$)
Table 133. Hitachi Medical Corporation (US) Recent Development
Table 134. Canon Medical Systems Corporation (Japan) Company Details
Table 135. Canon Medical Systems Corporation (Japan) Business Overview
Table 136. Canon Medical Systems Corporation (Japan) Product
Table 137. Canon Medical Systems Corporation (Japan) Revenue in Pulmonary Edema Treatment Business (2015-2020) (Million US$)
Table 138. Canon Medical Systems Corporation (Japan) Recent Development
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Pulmonary Edema Treatment Market Share by Type: 2020 VS 2026
Figure 2. Diagnosis Features
Figure 3. Treatment Features
Figure 4. Global Pulmonary Edema Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospitals and Clinics Case Studies
Figure 6. Academic Institutes Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Household Case Studies
Figure 9. Other Case Studies
Figure 10. Pulmonary Edema Treatment Report Years Considered
Figure 11. Global Pulmonary Edema Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Pulmonary Edema Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Pulmonary Edema Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Pulmonary Edema Treatment Market Share by Players in 2019
Figure 16. Global Top Pulmonary Edema Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pulmonary Edema Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Pulmonary Edema Treatment Revenue in 2019
Figure 18. North America Pulmonary Edema Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Pulmonary Edema Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Pulmonary Edema Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Pulmonary Edema Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Pulmonary Edema Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Pulmonary Edema Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Pulmonary Edema Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Pfizer Inc (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Pfizer Inc (US) Revenue Growth Rate in Pulmonary Edema Treatment Business (2015-2020)
Figure 27. ARGON MEDICAL (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. ARGON MEDICAL (US) Revenue Growth Rate in Pulmonary Edema Treatment Business (2015-2020)
Figure 29. Edwards Lifesciences Corporation (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Edwards Lifesciences Corporation (US) Revenue Growth Rate in Pulmonary Edema Treatment Business (2015-2020)
Figure 31. BD (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. BD (US) Revenue Growth Rate in Pulmonary Edema Treatment Business (2015-2020)
Figure 33. Alcaliber S.A. (Spain) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Alcaliber S.A. (Spain) Revenue Growth Rate in Pulmonary Edema Treatment Business (2015-2020)
Figure 35. Lupin Pharmaceuticals (India) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Lupin Pharmaceuticals (India) Revenue Growth Rate in Pulmonary Edema Treatment Business (2015-2020)
Figure 37. Vitaltec Corporation (China) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Vitaltec Corporation (China) Revenue Growth Rate in Pulmonary Edema Treatment Business (2015-2020)
Figure 39. Medtronic (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Medtronic (US) Revenue Growth Rate in Pulmonary Edema Treatment Business (2015-2020)
Figure 41. Koninklijke Philips N.V. (The Netherlands) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Koninklijke Philips N.V. (The Netherlands) Revenue Growth Rate in Pulmonary Edema Treatment Business (2015-2020)
Figure 43. Siemens Healthcare (Germany) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Siemens Healthcare (Germany) Revenue Growth Rate in Pulmonary Edema Treatment Business (2015-2020)
Figure 45. Hitachi Medical Corporation (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Hitachi Medical Corporation (US) Revenue Growth Rate in Pulmonary Edema Treatment Business (2015-2020)
Figure 47. Canon Medical Systems Corporation (Japan) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Canon Medical Systems Corporation (Japan) Revenue Growth Rate in Pulmonary Edema Treatment Business (2015-2020)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed